Clinical validation of myOSLchip: A beryllium oxide optically stimulated luminescent dosimeter (OSLD) system in radiotherapy dosimetry
In radiation oncology, inter-fractional dosimetry using optically stimulated luminescent detectors (OSLDs) ensures accurate plan delivery and patient safety. RadPro International GmbH's myOLSchip system, featuring a beryllium oxide (BeO) OSL dosimeter, reader, and eraser, was characterized and calibrated with a Varian Truebeam for in-vivo dosimetry following AAPM TG-191 guidelines. The BeO detectors demonstrated good dose linearity and repeatability across multiple exposures and erasure cycles, aligning with the manufacturer's stated accuracy and precision.
Authors
- Jeffrey V. Siebers (ORCID: https://orcid.org/0000-0002-9949-2863)
- K. Wijesooriya (ORCID: https://orcid.org/0000-0002-4283-1609)
- H. L. Davis (ORCID: https://orcid.org/0009-0009-6141-8957)
- Matt Mistro
Institutions
- University of Virginia (US)
Publication Details
- Journal
- Journal of Applied Clinical Medical Physics
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1002/acm2.70094
- Citations
- 3
- Primary Topic
- Advanced Radiotherapy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 5.65